NeOnc Technologies Holdings, Inc. (NTHI)
Last updated: 2026-11-18 07:53:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
NeOnc Technologies Holdings, Inc. (NTHI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.35, with a market capitalization of $130.98M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.50 to $11.38. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$130.98M | |
$4.51 | |
$5.16 | |
$4.32 | |
$4.54 | |
258.24K | |
182.02K | |
-- | |
$11.38 | |
$2.50 | |
-- | |
-- |
NeOnc Technologies Holdings, Inc. (NTHI) Latest Closing Stock Price
NeOnc Technologies Holdings, Inc. (NTHI) last closed at $4.35 as of 2026-11-18 00:31:00, down 4.19% ($0.19) from the previous close of $4.54.
During the latest regular trading session, NTHI traded between $4.32 and $5.16, with a volume of 258.24K shares. The closing price was near the lower end and near the lower end of its 52-week range.
NeOnc Technologies Holdings, Inc. (NTHI) 7-Day Stock Price Change
Over the past seven days, NeOnc Technologies Holdings, Inc. (NTHI) moved from $3.74 to $4.35, representing a gain of 16.18% ($0.60).
The stock traded between $3.52 and $5.44 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 304.53 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
NTHI 52-Week Price Position
Position in Range: 20.8%
NTHI is currently trading at $4.35, placing it 20.8% of the way from its 52-week low of $2.50 to its 52-week high of $11.38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is NeOnc Technologies Holdings, Inc. (NTHI)?
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
NeOnc Technologies Holdings, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 5 |
| Exchange | NASDAQ |
| Company Website |
NTHI News
Latest news related to NeOnc Technologies Holdings, Inc. and NTHI stock.
- Read Full Article
- Read Full Article
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Aytu BioPharma (NASDAQ:AYTU) shares rose 45.0% to $2.64 during Tuesday's pre-market session. The market value of their outstanding shares is at $19.7 million. The company's, Q1 earnings came out
- Read Full Article
Brain Cancer Biotech Race Heats Up as NeOnc, Nuvation, Jazz and Cerenome Present New Data at SNO
Four biotechnology companies presented clinical findings and emerging treatment approaches for brain cancers at the 31st Annual Meeting of the Society for Neuro-Oncology in Philadelphia. NeOnc Technologies is preparing for FDA meetings on two programs (NEO100 and NEO212), Cerenome is advancing REYOBIQ therapy and diagnostic tools, Nuvation Bio is expanding data on safusidenib for IDH1-mutant gliomas, and Jazz Pharmaceuticals is progressing dordaviprone through Phase 3 trials for rare brain cancers.
- Read Full Article
NeOnc Technologies Presents Updated Findings From Two Investigational Brain Cancer Programs, Intranasal NEO100 And Oral NEO212, At 31st Annual Meeting Of SNO
- Read Full Article
NeOnc Technologies CEO Buys 70K Shares At Average Price Of $4.21/Share; CMO Buys 5,016 Shares At Average Price Of $3.99/Share
Ways to Trade NTHI at MEXC
How to Buy NeOnc Technologies Holdings, Inc. (NTHI) Stock on MEXC
Eligible investors can buy real shares of NeOnc Technologies Holdings, Inc. (NTHI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is NeOnc Technologies Holdings, Inc. (NTHI) stock price today?
2.Is NTHI stock going up or down today?
3.What is NTHI pre-market price?
4.What is NTHI after-hours price?
5.Is NTHI stock trading now?
6.Where does NTHI sit relative to its 52-week high and low?
7.What sector is NeOnc Technologies Holdings, Inc. in?
8.What is NeOnc Technologies Holdings, Inc.'s market capitalization and where is it listed?
9.How is NTHI valued in terms of P/E ratio and EPS?
10.Does NeOnc Technologies Holdings, Inc. pay a dividend?
Explore More US Stocks
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to NTHI, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
NTHI Stock Calculator
Estimate the value between NTHI shares and USD.
NTHI Shares to USD
1.00 NTHI shares = 4.345 USD
Calculations are estimates based on the latest available price and are for reference only.


